Salarius Pharmaceuticals, Inc. (SLRX) earnings
SLRX earnings moved a median of -3.43% by the close. Quarterly and annual SLRX reports and results, each read against the price at its own news timestamp. Back to the SLRX overview →
11 measured SLRX earnings events.
Where these SLRX earnings landedvs 11 measured SLRX earnings reactions
| Middle 50% of SLRX earnings reactions | -9.32% to -2.15% |
|---|---|
| Median reaction (to close) | -3.43% |
| Measured reactions | 11 |
Point-in-time · zero look-ahead
Half of the 11 SLRX earnings events with a measured close landed between -9.32% and -2.15%; 9% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Salarius Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -0.44% | -18.66% | |
| Strong Earnings and Biotech Resilience Define the Midweek Momentum | Press release | -9.79% | -9.09% | |
| Form 10-Q Salarius Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +4.06% | -1.26% | |
| Form 10-Q Salarius Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -4.54% | -3.43% | |
| Form 10-K Salarius Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +2.48% | +3.32% | |
| Form 10-Q Salarius Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -0.72% | -2.90% | |
| Form 10-Q Salarius Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -9.00% | -9.54% | |
| Form 10-Q Salarius Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +0.73% | -4.73% | |
| Form 10-K/A Salarius Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.76% | |
| Form 10-K Salarius Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | -6.42% | -31.82% | |
| Form 10-Q Salarius Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -5.06% | -2.53% |
Keep exploring
More SLRX: analyst actions → · SEC filings → · SLRX overview →